Clinical Trial: A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954558) titled 'A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor' on April 14.

Brief Summary: This study is a Phase I, open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.

Study Start Date: March 18

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: GK01 Injection

Autologous tumor-reactive T cells injection

Recruitment Status: RECRUITING

Sponsor: Tianjin Medical University Cancer Institute and Hospital

Disclaimer: Curated by HT Syndication....